Did you or someone you love take prescription or over-the-counter Zantac to treat heartburn or acid reflux? If so, you may have been exposed to a contaminant called N-nitrosodimethylamine, which is a probable carcinogen and is linked to multiple types of cancers of vital organs and the digestive system. The contaminant was also found in generic versions of the drug (ranitidine).
The discovery prompted the U.S. Food and Drug Administration to advise a recall of all ranitidine-containing products, including both name brand and generic Zantac tablets. As of March 2020, these products have been removed from virtually all pharmacy, supermarket, and hospital shelves. However, people who took the drugs previously, whether briefly or for many years, may have experienced an increased risk of cancer.
At Lowell Stanley Injury Lawyers, our Virginia drug injury attorneys are here to help anyone who was diagnosed with cancer after taking Zantac or its generic equivalents. The manufacturers of these tablets should have been aware that their products were tainted with dangerous impurities and contaminants, but they failed to properly test them. That led to potentially millions of people being exposed to carcinogens.
If you still take Zantac, talk to your doctor about alternative options for treating acid reflux. Other medications can also control symptoms, as can diet and lifestyle changes. And if you or someone you love experienced significant health problems after taking Zantac, including being diagnosed with cancer, our legal team is here to help. Contact us today for a free consultation. It’s our goal to get you the money you deserve for your pain and suffering.